In lung cancer (Wang et al., 2019), osteosarcoma (Lu et al., 2020) and retinoblastoma (He and Qin, 2020), it has been reported that LEF1-AS1 is an upregulated oncogene promoting tumor progression. This evidence concerns the gene LEF1 and neoplasm.